Physician profile
Bennett I Machanic
NPI 1952352593
$4,357.47
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,745 · 2020: $477 · 2021: $136.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,153.62 | 2019-2020 | |
| Genzyme Corporation | $649.60 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $470.93 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $381.64 | 2019-2021 | |
| Biogen, INC. | $297.56 | 2019 | |
| Mallinckrodt Enterprises LLC | $281.91 | 2019 | |
| Ucb, INC. | $259.24 | 2019-2020 | |
| Genentech USA, INC. | $228.72 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $168.79 | 2019 | |
| Allergan, INC. | $123.54 | 2019-2020 | |
| Assertio Therapeutics, INC. | $97.46 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $57.09 | 2019 | |
| Vertical Pharmaceuticals, LLC | $40.40 | 2019-2020 | |
| Boston Scientific Corporation | $34.85 | 2019 | |
| Neurelis, INC. | $34.62 | 2020-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $26.64 | 2019 | |
| Mallinckrodt Hospital Products INC. | $20.98 | 2020 | |
| Grifols USA, LLC | $18.78 | 2019 | |
| Csl Behring | $11.10 | 2019 |
6 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett Machanic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.